How is MHRA Improving Regulatory Pathways for Rare Disease Therapies in the UK?
The MHRA has published its intentions to improve regulatory pathways for rare disease therapies to be tested, manufactured and approved in the UK.
How is MHRA Improving Regulatory Pathways for Rare Disease Therapies in the UK? Read More »